$PVLA
Palvella Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$150.56
▼-2.44%-$3.76
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePalvella Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is PVLA down today? It is at $150.56 (-2.44%), and our scanner flagged it 26 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PVLA spikes, and full due diligence on PVLA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PVLA 26 times in the last 30 days. Create a free account to track $PVLA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on PVLA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PVLA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPALVELLA THERAPEUTICS, INC.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Goin Kathleen Officer | Sold (automatic/other) | -4K 0.03% of company | n/a | n/a | $650K at $151.16 | Sep 16, 26 |
Goin Kathleen Officer | Other | 4K 0.03% of company | n/a | 4K | $31K at $7.14 | Sep 16, 26 |
Jenkins George M Director | Sold (automatic/other) | -2K 0.01% of company | sold 1.1% | 160K | $265K at $149.38 | Sep 15, 26 |
Jenkins George M Director | Sold (automatic/other) | -13K 0.09% of company | sold 7.6% | 162K | $2.0M at $151.46 | Sep 14, 26 |
Jenkins George M Director | Sold (automatic/other) | -12K 0.09% of company | sold 6.6% | 175K | $1.9M at $150.62 | Sep 11, 26 |
Kiritsy Christopher P Director | Sold (automatic/other) | -313 | sold 56% | 250 | $49K at $157.00 | Sep 2, 26 |
Kiritsy Christopher P Director | Other | 313 | added 100% | 563 | $40K at $127.20 | Sep 2, 26 |
Goin Kathleen Officer | Sold (automatic/other) | -4K 0.03% of company | n/a | n/a | $651K at $151.39 | Aug 19, 26 |
Goin Kathleen Officer | Other | 4K 0.03% of company | n/a | 4K | $31K at $7.14 | Aug 19, 26 |
Goin Kathleen Officer | Sold (automatic/other) | -4K 0.03% of company | n/a | n/a | $633K at $147.14 | Jul 15, 26 |
Goin Kathleen Officer | Other | 4K 0.03% of company | n/a | 4K | $31K at $7.14 | Jul 15, 26 |
Goin Kathleen Officer | Sold (automatic/other) | -4K 0.03% of company | n/a | n/a | $474K at $110.26 | Jun 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on PVLA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for PVLA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
PVLA last traded at $150.56, down 2.44% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Palvella Therapeutics, Inc. Common Stock (PVLA) is next expected to report earnings on Tuesday, November 10, 2026, about 51 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The PVLA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PVLA 26 times in the last 30 days.
PVLA (Palvella Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $2.17B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PVLA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PVLA discussion
Sign in to ask a question or join the discussion.